When used for weight management, Semaglutide GLP-1 helps slow the emptying of food from the stomach, which increases feelings of fullness and reduces hunger
Advertisement Large retrospective analysis may prompt prospective studies How to talk about lifetime risk, treatment goals, Lp(a) testing, statin skepticism and more Robust signal from observational study raises prospect of a long-sought medical therapy Retrospective analysis finds lower mortality rates, fewer hospital visits among patients with Type 1 diabetes using GLP-1 Therapies Study shows significantly reduced risk of mortality and disease complications in patients receiving GLP-1 agonists Observational evidence of neuroprotection with GLP-1 receptor agonists and SGLT-2 inhibitors Study is first to show reduction in autoimmune disease with the common diabetes and obesity drugs Surgical intervention linked to increased lifespan and reduced complications
Risks of Fragmented Care Models As remote prescribing of GLP-1 therapies expands, fragmented care has become a growing concern
For instance, pH-sensitive systems release drugs in the acidic tumor microenvironment and temperature-responsive systems are activated in injured/tumor tissues where the local temperature is increased
Fig.3 Plate Diagram: an example of the GSH standard solution and sample solution arrangement to be measured in triplicate (up to 24 samples can be determined in one plate)
